The Anderson Analysis
A masterclass in the strategic forces driving industrial and systemic change.
About This Column
Known for his "critical assessments" of emerging technologies, Charles Anderson brings rigorous analytical depth to a new, expansive beat. Building on a career spent at the intersection of medicine and technology, Charles now tracks the cross-industry trends where innovation meets real-world execution. He specializes in the practical application of new business models - uncovering the quantifiable benefits and the hidden challenges companies face when implementing complex transformations. His column offers actionable intelligence for leaders who value resilient, efficient, and human-centered strategies over mere hype.
Displaying items 261-280 of 499 in total
YCharts, Hamilton Lane Tackle Private Markets Data Gap for Advisors
BC's 'Green Nickel' Giant Faces Public Scrutiny in EV Supply Race
Lumiere Awards: AI and Tech Redefine Hollywood's Creative Future
Agomab Raises $200M in IPO to Tackle Chronic Fibrotic Diseases
Beyond the Counter: Pharmacists Hailed as Public Health Champions
Corporate Dermatology Grows as Arlington Clinic Joins Epiphany Network
Luminar Unwinds: Asset Sales Fund Debt Offer Amid Chapter 11 Liquidation
IVF Drug Costs Slashed in White House-Pharma Partnership
Abu Dhabi Waives Art Tariffs to Attract Global Masterpieces
PharmaResearch Gets FDA Nod for Novel Nano-Cancer Drug Trial
Titans of Play: Pulse of Play Awards Crown 2026's Top Toy Innovators
VR Surgery: A New Vision in the Fight Against Global Blindness
Saudi's Digital Shield: CrowdStrike & Aramco Forge Cyber Fortress
Breckenridge Distillery Taps Romano for Illinois Spirits Expansion
Registrar Corp Acquires TechniCAL, Forging a Food Safety Powerhouse
Flying High on Data: HAESL's Digital Leap with HCLTech
Webroot VPN Named Top Tool, But What Defines 'Best' in 2026?
Shareholder Revolt: Coloured Ties Battles Labrador Gold Board
From Tech CEO to Pilates Pro: BODYBAR Enters the Oregon Market
